I've never seen one of those algorithms website able to accurately predict any Biotech stock share price or trend.
The key for researching Biotechs especially smaller cap ones is what is the Total Addressable Markets for each indication and potential of the current drug clinical trials to get there.
So best is to start with ASX announcements and CEO Investor Presentations to see what the company is trying to do to break down the science and company trajectory.
eg. Are they trying something completely novel and new, or is it an improvement on existing tech, where more easily comparable.
PXS is a bit of a rarity in that it actually has 2 approved and marketed drugs, but as they are manufactured and marketed locally the cost bases is a lot higher than if this was outsourced, but there has been some great developments in licencing out the expense of marketing and selling these drugs which will significantly reduce their current cash burn rate.
Today's announcement should have a meaningful impact to the Q3 quarterly report figures.
- Forums
- ASX - By Stock
- SNT
- Chart and TA
Chart and TA, page-56
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
-0.001(3.03%) |
Mkt cap ! $42.58M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.2¢ | $42.14K | 1.285M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 223941 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 479834 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 223941 | 0.032 |
3 | 832580 | 0.031 |
6 | 1933333 | 0.030 |
12 | 2207772 | 0.029 |
4 | 1430000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 479834 | 6 |
0.034 | 125377 | 3 |
0.035 | 1000000 | 1 |
0.036 | 98567 | 1 |
0.037 | 134500 | 1 |
Last trade - 12.37pm 23/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online